Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Amgen 10.054.
Pfizer vs Amgen: Revenue Comparison
Pfizer (PFE) and Amgen (AMGN) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $10.1B for Amgen. Pfizer leads on revenue.
Pfizer's gross margin is 72.8% versus 72.0% for Amgen. Pfizer's net margin is -1.6% versus 23.6% for Amgen.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Amgen.| Metric | Pfizer | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $10.05B |
| Cost of Revenue | $4.09B | $2.81B |
| Gross Profit | $10.94B | $7.24B |
| Operating Income | $4.71B | $3.51B |
| Net Income | $-246.00M | $2.38B |
| R&D Expense | $2.81B | $1.87B |
| Earnings Per Share | -$0.04 | $4.37 |
| Gross Margin | 72.8% | 72.0% |
| Operating Margin | 31.3% | 35.0% |
| Net Profit Margin | -1.6% | 23.6% |
| Free Cash Flow | $302.00M | $3.49B |
| Cumulative Free Cash Flow | $356.70B | $169.18B |
| Operating Cash Flow | $835.00M | $4.00B |
| Cash & Equivalents | $976.00M | $13.99B |